Immune Mechanisms Linking Obesity and Preeclampsia

Area of Science:

• Reproductive Immunology
• Maternal-Fetal Medicine
• Pathophysiology of Hypertension

Background:

• Preeclampsia (PE) is a pregnancy complication marked by hypertension after 20 weeks.
• PE significantly contributes to maternal and perinatal mortality globally, with increasing prevalence in developed nations.
• The exact mechanisms driving PE pathogenesis and its rising incidence remain unclear.

Purpose of the Study:

• To review the immune mechanisms involved in preeclampsia pathogenesis.
• To emphasize the role of inflammation in preeclampsia, particularly in obese pregnancies.
• To explore how obesity influences the risk and development of preeclampsia.

Main Methods:

• Review of current literature on preeclampsia, immunology, and obesity.
• Analysis of proposed mechanisms linking placental ischemia, endothelial dysfunction, and hypertension.
• Examination of the role of immune cells and inflammatory cytokines in PE.

Main Results:

• Placental ischemia may trigger soluble factors causing endothelial dysfunction and hypertension.
• Aberrant maternal immune responses and inflammation are implicated in PE development.
• Obesity, a state of chronic inflammation, is linked to increased PE risk via immune cell activation and cytokine production.

Conclusions:

• Immune dysregulation and inflammation are central to preeclampsia pathogenesis.
• Obesity presents a significant risk factor for PE, mediated by inflammatory pathways.
• Understanding these immune mechanisms is crucial for addressing the rising prevalence of PE, especially in obese pregnancies.